Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer

SIMPLE SUMMARY: Hormonal treatments, especially those used to treat menopause symptoms are known to increase breast cancer risk. It is thus necessary to identify new formulations with a better benefit/risk profile. The aim of this translational study was to evaluate the breast cancer risk associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallez, Anne, Blacher, Silvia, Maquoi, Erik, Konradowski, Erika, Joiret, Marc, Primac, Irina, Gérard, Céline, Taziaux, Mélanie, Houtman, René, Geris, Liesbet, Lenfant, Françoise, Marangoni, Elisabetta, Sounni, Nor Eddine, Foidart, Jean-Michel, Noël, Agnès, Péqueux, Christel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160902/
https://www.ncbi.nlm.nih.gov/pubmed/34065180
http://dx.doi.org/10.3390/cancers13102486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160902/
https://www.ncbi.nlm.nih.gov/pubmed/34065180
http://dx.doi.org/10.3390/cancers13102486

Ejemplares similares